Found 15 matching trials
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort
PHASE3The goal of this clinical trial is to compare the efficacy and safety of a ...
Status
Active Not Recruiting
Location
Beijing Chest Hospital affiliated to Capital Medical University
Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance
N/AThe principal objective is to evaluate a cure rate and number of adverse ev...
Location
Centre de Recherches Médicales de Lambaréné
Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan
N/AMultidrug resistant tuberculosis (MDR TB) is a growing problem and few peop...
Location
Outpatient clinics in three districts
Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
PHASE3The proposed study will randomize adults (18 years of age or older) with pu...
Location
Multiple Locations
The Individualized M(X) Drug-resistant TB Treatment Strategy Study
PHASE4This is a randomized controlled clinical trial comparing treatment success ...
Location
King Dinuzulu Hospital
Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
NAThis study is a randomized, controlled, multi-center clinical study. The ma...
Location
Beijing Chest Hospital affiliated to Capital Medical University
Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)
PHASE4The purpose of this study is to assess the efficacy, safety and tolerabilit...
Location
The Third People's Hospital of Shenzhen City
High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis
PHASE2The need for a standardized treatment protocol for multidrug resistant tube...
Location
Multiple Locations
NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB
NATuberculosis (TB) has been one of the top 10 causes of death worldwide from...
Location
The Third People's Hospital of Shenzhen City
Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents
PHASE1This study aims to investigate the pharmacokinetic characteristics of secon...
Location
Seoul National University Bundang Hospital